# Diagnosis of Multiple Fundus Disorders Amidst a Scarcity of Medical Experts Via Self-supervised Machine Learning

arXiv: https://arxiv.org/abs/2404.13388 · HTML: https://mlsanity.com/paper/2404.13388/

## Key facts

- No citing papers in the map yet (data through 14 Oct 2026).
- Builds on 7 of its 47 references that are in the map.
- First posted on arXiv 20 Apr 2024.

## Builds on (most cited first, 7 of 7)

- [Self-supervised Feature Learning via Exploiting Multi-modal Data for Retinal Disease Diagnosis](https://mlsanity.com/paper/2007.11067/) (2020)
- [CANet: Cross-disease Attention Network for Joint Diabetic Retinopathy and Diabetic Macular Edema Grading](https://mlsanity.com/paper/1911.01376/) (2019)
- [How Transferable Are Self-supervised Features in Medical Image Classification Tasks?](https://mlsanity.com/paper/2108.10048/) (2021)
- [Detecting hidden signs of diabetes in external eye photographs](https://mlsanity.com/paper/2011.11732/) (2020)
- [A Deep Learning based Joint Segmentation and Classification Framework for Glaucoma Assesment in Retinal Color Fundus Images](https://mlsanity.com/paper/1808.01355/) (2018)
- [Semi-weakly Supervised Contrastive Representation Learning for Retinal Fundus Images](https://mlsanity.com/paper/2108.02122/) (2021)
- [A deep learning model for classification of diabetic retinopathy in eye fundus images based on retinal lesion detection](https://mlsanity.com/paper/2110.07745/) (2021)

## Abstract (arXiv)

Fundus diseases are major causes of visual impairment and blindness worldwide, especially in underdeveloped regions, where the shortage of ophthalmologists hinders timely diagnosis. AI-assisted fundus image analysis has several advantages, such as high accuracy, reduced workload, and improved accessibility, but it requires a large amount of expert-annotated data to build reliable models. To address this dilemma, we propose a general self-supervised machine learning framework that can handle diverse fundus diseases from unlabeled fundus images. Our method's AUC surpasses existing supervised approaches by 15.7%, and even exceeds performance of a single human expert. Furthermore, our model adapts well to various datasets from different regions, races, and heterogeneous image sources or qualities from multiple cameras or devices. Our method offers a label-free general framework to diagnose fundus diseases, which could potentially benefit telehealth programs for early screening of people at risk of vision loss.
